Atypical Chest Pain: Coronary, Aortic, and Pulmonary Vasculature Enhancement at Biphasic Single-Injection 64-Section CT Angiography

Purpose: To prospectively evaluate the enhancement of coronary, pulmonary, and thoracic aortic vasculature by using biphasic single-acquisition 64-section computed tomographic (CT) angiography and to prospectively evaluate if differences in right side of the heart and coronary venous enhancement interfere with interpretation of coronary arteries.

Materials and Methods: With internal review board approval and HIPAA compliance, 50 patients (16 men, 34 women; mean age, 51.5 years; range, 30–75 years) with atypical chest pain were referred from the emergency department and were imaged with a 64-section CT scanner after premedication with oral atenolol and/or intravenous metoprolol. Thoracic CT angiography with retrospective gating was subsequently performed with a single biphasic injection of 130 mL of iso-osmolar contrast material (100 mL at 5 mL/sec and 30 mL at 3 mL/sec) in caudal-to-cranial acquisition. Coronary, aortic, and pulmonary arterial attenuation values were obtained. Coronary venous and right atrial enhancement were evaluated to assess whether there was interference with coronary artery evaluation. A two-tailed Friedman test was used to evaluate differences among segments within each artery.

Results: Mean coronary arterial, pulmonary arterial, and aortic attenuation values were significantly higher than the 250-HU threshold (P < .05). Mean pooled coronary arterial (288.9 HU ± 64.8), pulmonary arterial (316.4 HU ± 79.9), and aortic (329.9 HU ± 63.3) attenuation values were significantly higher than the 250-HU threshold (P < .0001). Coronary venous enhancement did not affect depiction or interpretation of coronary arteries. Right atrial streak artifact focally traversed the right coronary artery in only one study.

Conclusion: The aforementioned thoracic CT angiographic protocol provides enhancement of coronary, aortic, and pulmonary vasculature in a single breath hold without interference from right side of the heart streak artifact or coronary venous enhancement.

© RSNA, 2007

References

  • 1 Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–842.
  • 2 Cademartiri F, Nieman K, van der Lugt A, et al. Intravenous contrast material administration at 16–detector row helical CT coronary angiography: test bolus versus bolus-tracking technique. Radiology 2004; 233: 817–823.
  • 3 Wittram C, Maher MM, Yoo AJ, Kalra MK, Shepard JA, McLoud TC. CT angiography of pulmonary embolism: diagnostic criteria and causes of misdiagnosis. RadioGraphics 2004; 24: 1219–1238.
  • 4 Patel S, Kazerooni EA, Cascade PN. Pulmonary embolism: optimization of small pulmonary artery visualization at multi–detector row CT. Radiology 2003; 227: 455–460.
  • 5 Dix JE, Evans AJ, Kallmes DF, Sobel AH, Phillips CD. Accuracy and precision of CT angiography in a model of carotid artery bifurcation stenosis. AJNR Am J Neuroradiol 1997; 18: 409–415.
  • 6 Becker CR, Hong C, Leber A, et al. Optimal contrast application for cardiac 4-detector-row computed tomography. Invest Radiol 2003; 38: 690–694.
  • 7 Jones SE, Wittram C. The indeterminate CT pulmonary angiogram: imaging characteristics and patient clinical outcome. Radiology 2005; 237: 329–337.
  • 8 Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease: report of the Ad-Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery. Circulation 1975; 51: 5–40.
  • 9 Bae KT, Tran HQ, Heiken JP. Multiphasic injection method for uniform prolonged vascular enhancement at CT angiography: pharmacokinetic analysis and experimental porcine model. Radiology 2000; 216: 872–880.
  • 10 Fleischmann D, Rubin GD, Bankier AA, Hittmair K. Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography. Radiology 2000; 214: 363–371.
  • 11 Bae KT, Tran HQ, Heiken JP. Uniform vascular contrast enhancement and reduced contrast medium volume achieved by using exponentially decelerated contrast material injection method. Radiology 2004; 231: 732–736.
  • 12 Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? pharmacokinetic study in a porcine model. Radiology 2003; 227: 809–816.
  • 13 Bedard JP, Blais C, Patenaude YG, Monga E. Pulmonary embolism: prospective comparison of iso-osmolarity nonionic contrast agents for contrast enhancement at CT angiography. Radiology 2005; 234: 929–933.
  • 14 Schoellnast H, Deutschman HA, Fritz GA, Stessel U, Schaffler GJ, Tillich M. MDCT angiography of the pulmonary arteries: influence of iodine flow concentration on vessel attenuation and visualization. AJR Am J Roentgenol 2005; 184: 1935–1939.
  • 15 Jensen CT, Ravenel JG, Nguyen SA, Costello P, Schoepf UJ. Dual flow contrast injection for coronary CTA improves visualization of the right heart [abstr]. Int J Cardiovasc Imaging 2005; 21(6): 696.
  • 16 Kirchner J, Kickuth R, Laufer U, Noack M, Liermann D. Optimized enhancement in helical CT: experiences with a real-time bolus tracking system in 628 patients. Clin Radiol 2000; 55: 368–373.

Article History

Published in print: 2007